MENU

SB-FinFET: Asymmetric Triple-Channel Biosensor Specs for Cardiac Biomarkers

Research Square
Overview
Researchers have designed and simulated an asymmetric triple-channel Schottky barrier FinFET (SB-FinFET) for label-free detection of cardiac biomarker proteins. The device achieves an I ON /I OFF ratio of approximately 1 x 10 8 for target biomolecules with dielectric constants between k = 1.5–3.5. This architecture offers a low-complexity, cost-effective alternative to NC-FET and TFET structures for point-of-care diagnostics.
In Depth

Key Findings

The SB-FinFET demonstrates high sensitivity in detecting cardiac biomarkers, achieving an I ON /I OFF ratio of approximately 1 x 10 8 and a low subthreshold swing. These results apply to target biomolecules with dielectric constants in the range of k = 1.5–3.5, including troponin, streptavidin, and uricase. Performance was further validated through transconductance (g m) linearity analysis and third-order nonlinearity metrics, specifically VIP 3 and IIP 3.

Technical Details

The device utilizes an asymmetric, triple-channel stacked architecture where three channels are positioned vertically. The materials and specifications include:

  • Channel Material: Silicon carbide (SiC).
  • Contacts: Nickel silicide (NiSi) Schottky contacts.
  • Gate Dielectric: Hafnium oxide (HfO 2 ) to improve electrostatic coupling and reduce intrinsic leakage current.
  • Channel Configuration: The architecture decouples current driving ability from sensing ability via varied doping levels. The two outer channels are 4 nm deep with a doping density of 1 x 10 17 cm − 3 to provide gain and current drive. The central channel is 1 nm thick with a doping density of 1 x 10 10 cm − 3, acting as the high-sensitivity transducer that converts protein interactions into electrical signals.

Background & Context

The SB-FinFET was compared against other device structures, specifically Tunnel FETs (TFETs) and Negative Capacitance FETs (NC-FET). While the performance of the SB-FinFET is similar to these technologies, it is characterized by lower fabrication complexity and lower costs.

Significance & Outlook

By combining high sensitivity with reduced manufacturing complexity, the SB-FinFET serves as an experimental platform for the development of new cardiac diagnostic devices. This technology is positioned to enable rapid diagnosis at or near the site of patient care.

Source: https://doi.org/10.21203/rs.3.rs-11230907/v1

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Published by Troy-Technical, an independent site run by one engineer with a career in materials development.
About the author / Contact info@troy-technical.jp
Let's share this post !

Author of this article

TOC